Enantioselective preparation of quinoline derivative

Details for Australian Patent Application No. 2005254698 (hide)

Owner Novartis AG

Inventors Vogel, Caspar; Penn, Gerhard; Lohse, Olivier

Agent Davies Collison Cave

Pub. Number AU-B-2005254698

PCT Pub. Number WO2005/123684

Priority 0413960.6 22.06.04 GB

Filing date 21 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 25 September 2008

International Classifications

C07D 215/00 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 251/26 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123684 Priority application(s): WO2005/123684

7 June 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Enantioselective preparation of quinoline derivative

25 September 2008 Application Accepted

  Published as AU-B-2005254698

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254704-Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

2005254692-Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxydase in the seeds